The goal of this observational study is to assess whether the continuous non-invasive haemodynamic monitor MOH200 (measuring blood pressure as well as pulse rate) is effective or not in people undergoing general anesthetic surgeries for more than 60 minutes with planned invasive blood pressure and pulse oximeter monitoring. Researchers will compare blood pressure data derived from MOH200 to the invasive blood pressure (IBP) data to see if the MOH200 is effective to measure the blood pressure of a surgical person. Also, researchers will compare pulse rate data drived from MOH200 to that from the pulse oximeter to see if the MOH200 is effective to measure the pulse rate of a surgical person. Participants will be asked to be applied with MOH200 monitoring while IBP monitoring and pulse oximeter are applied. And after 30 minutes of the surgery, researchers will monitor the adverse effects occurred on the skin of participants to assess the safety of MOH200.
Study Type
OBSERVATIONAL
Enrollment
55
Continuous Non -invasive Blood Pressure Measurement from MOH200
The blood pressure is measured by MOH200 and recorded on the CRF for every 5 minutes, including mean blood pressure, diastolic blood pressure and systolic blood pressure.
Time frame: During the surgery
Invasive Blood Pressure Measurement from Arterial Line
The blood pressure is synchronously measured by the radial arterial line and also recorded on the CRF for every 5 minutes, including mean arterial pressure, diastolic blood pressure and systolic blood pressure.
Time frame: During the surgery
Pulse Rate Measurement from MOH200
The pulse rate is measured by the MOH200 and recorded on the CRF for every 5 minutes.
Time frame: During the surgery
Pulse Rate Measurement from Pulse Oximeter
The pulse rate is measured by the pulse oximeter and recorded on the CRF for every 5 minutes during the surgery.
Time frame: During the surgery
The Occurrence of Pressure Pores
In order to evaluate the safety of the haemodynamic monitor MOH200, the occurrence of device-related pressure pores is recorded. The incidence of adverse reactions=(the number of pressure sore occurrence/the total number of subjects observed)×100%
Time frame: Once after all the subjects are recruited and the clinical trials are finished
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.